Found: 13
Select item for more details and to access through your institution.
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248017
- By:
- Publication type:
- Article
Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia.
- Published in:
- Global Health: Science & Practice, 2018, v. 6, n. 4, p. 723, doi. 10.9745/GHSP-D-18-00157
- By:
- Publication type:
- Article
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 1, p. 1, doi. 10.1002/pds.4125
- By:
- Publication type:
- Article
Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0166649
- By:
- Publication type:
- Article
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2369, doi. 10.2147/PPA.S116860
- By:
- Publication type:
- Article
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 9, p. 1052, doi. 10.1002/pds.4022
- By:
- Publication type:
- Article
Comparing amikacin and kanamycininduced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, p. 1, doi. 10.1186/s40360-015-0036-7
- By:
- Publication type:
- Article
Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2014, v. 7, n. 10, p. 7, doi. 10.1186/2052-3211-7-14
- By:
- Publication type:
- Article
Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1087, doi. 10.1007/s40264-013-0091-1
- By:
- Publication type:
- Article
The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia.
- Published in:
- Southern Med Review, 2012, v. 5, n. 1, p. 6
- By:
- Publication type:
- Article
Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 4, p. 407, doi. 10.1002/pds.2252
- By:
- Publication type:
- Article